OPCH vs. CHE: Which Stock Is the Better Value Option?
Portfolio Pulse from
A comparative analysis reveals Option Care Health (OPCH) as a more attractive value investment compared to Chemed (CHE). OPCH has a stronger Zacks Rank (#1 Strong Buy vs CHE's #4 Sell), more favorable valuation metrics including a lower forward P/E ratio (20.38 vs 24.24), lower PEG ratio (1.82 vs 2.37), and a more attractive price-to-book ratio (4.18 vs 8.12).
March 20, 2025 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CHE receives a less favorable analysis with a Zacks Rank #4 (Sell) and less attractive valuation metrics compared to Option Care Health.
Sell ranking, higher valuation ratios, and weaker earnings estimate trends indicate potential downward pressure
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
OPCH demonstrates superior value metrics with a Zacks Rank #1, lower forward P/E, and more attractive valuation fundamentals compared to industry peer Chemed.
Strong Zacks Rank, favorable valuation metrics, and positive earnings estimate revisions suggest potential stock price appreciation
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100